Author： Baldi Alfonso Mottolese Marcella Vincenzi Bruno Campioni Mara Mellone Pasquale Di Marino Mariapia di Crescenzo Vincenzo G Visca Paolo Menegozzo Simona Spugnini Enrico P Citro Gennaro Ceribelli Anna Mirri Alessandra Chien Jeremy Shridhar Viji Ehrmann Michael Santini Mario Facciolo Francesco
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.9, Iss.8, 2008-08, pp. : 1069-1077
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Mitochondrial Serine Protease HtrA2/Omi as a Potential Therapeutic Target
Current Drug Targets, Vol. 10, Iss. 4, 2009-04 ,pp. :
Access to resources
Recommend
HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design, Vol. 19, Iss. 6, 2013-02 ,pp. :
HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. :
A novel structural motif for serine protease inhibitors
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. :
Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. :